Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost + brinzolamide versus fixed dorzolamide + timolol for glaucoma or ocular hypertension
2006-003627-37Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Aug 2006
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of travoprost, brinzolamide, dorzolamide and timolol in Glaucoma and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoints: Change from baseline in intraocular pressure, Area below the diurnal intraocular pressure curve and 2 more. Started Aug 2006; status: completed.
02
Drugs
travoprostbrinzolamidedorzolamidetimolol
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on 2006-003627-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003627-37.